Abstract: A mixed metal compound for pharmaceutical use is free from aluminum and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.

Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.

Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.

Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.

Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.

Abstract: The invention provides a use of a material comprising antimony silicate as a sorbent in the removal of metal ions, e.g. radioactive metal ions, from an acidic liquid medium. The metal ions may be selectively removed from amongst other ions such as Na, K, Mg, and Ca ions. Strontium is particularly effectively removable in this way. There is also provided a method of preparing an antimony silicate material for use in removing metal ions. The invention further provides a material comprising antimony silicate doped with one or more elements selected from the group consisting of tungsten, niobium and tantalum. The doped material has been found to be particularly effective as a sorbent in the removal of metal ions from a liquid medium.

Abstract: A non-aluminum containing mixed metal compound for pharmaceutical use, which may, for example, be a mixed metal hydroxy carbonate containing magnesium and iron, and may have a hydrotalcite structure, preferably a non-aged hydrotalcite structure. Other metals, including, for example, calcium, lanthanum and cerium, may also be used. Metal sulphate compounds, especially calcium sulphate, lanthanum sulphate and/or cerium sulphate, compounds are also useful. The mixed metal compounds have a phosphate binding capacity of at least 30%, by weight, based on the test methods 1, 2 or 3, described in the specification, over a pH range from 3 to 7, such as from 2 to 8. The compound is especially useful in the treatment of hyperphosphataemia.

Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.

Abstract: The invention provides a use of a material comprising antimony silicate as a sorbent in the removal of metal ions, e.g. radioactive metal ions, from an acidic liquid medium. The metal ions may be selectively removed from amongst other ions such as Na, K, Mg, and Ca ions. Strontium is particularly effectively removable in this way. There is also provided a method of preparing an antimony silicate material for use in removing metal ions. The invention further provides a material comprising antimony silicate doped with one or more elements selected from the group consisting of tungsten, niobium and tantalum. The doped material has been found to be particularly effective as a sorbent in the removal of metal ions from a liquid medium.

Abstract: Effluents containing residual dyes are contacted with an effective amount of hydrotalcite-like material together with an effective amount of a magnesium salt or a mixture of magnesium salts, the weight ratio (on dry basis) of hydrotalcite-like material to magnesium salt being in the range of 20:1 to 1:20. Residual dyes are removed from effluents.

Abstract: A method of treating a liquid medium to remove from it matter present therein comprises adding to the liquid medium at least one of an at least partially undried sorbing agent (a), a freshly prepared sorbing agent (b) and an in-situ sorbing agent (c). Sorbing agent (a) comprises a hydrotalcite-like material resulting from the preparation thereof in a liquid reaction medium, which preparation allows retention, in the hydrotalcite-like material, of at least 10% of free liquid, based on the weight of the hydrotalcite-like material, including the free liquid, and (a).sub.1 which sorbing agent is present in an amount, on a dry weight basis, of the sorbing agent, by volume of the liquid medium to be treated, of .ltoreq.0.035% w/v, or (a).sub.2 the preparation of the hydrotalcite-like material is such as to provide a grain size of the hydrotalcite-like material of .ltoreq.130 .ANG., as measured in the <001> direction by x-ray diffraction on a subsequently dried material.

Abstract: A hydrophobic porous inorganic carrier particle having at least a pore volume of 0.1 ml/g consisting of pores with a diameter of 7 to 50 .ANG. and having a perfume absorbed into said particle. The invention also comprises a detergent composition containing the carrier particle and a method of manufacturing the carrier particle.

Abstract: The removal of organo-toxins from aqueous sources can be achieved efficiently by contacting the water source with hydrotalcite-like materials. The toxins include organo-chlorines, insect resist agents, and wool treatment byproducts.

Abstract: It is necessary to remove unbound reactive dyes from the surfaces of textile substrates treated with dyes of this class; this is to ensure the dyed substrate is fast. In the invention dye is removed from a wash medium by contracting the medium with an absorbent, preferably a hydrotalcite-like material, which removes suspended dye. This removal allows re-use of the wash medium or its disposal.

Abstract: A detergent composition comprising a detergent active system, and a hydrotalcite-like material as defined in formula I,M.sub.k+m N.sub.n+p (OH).sub.2 A.sub.2.sup.Y- x. H.sub.2 O IM is any 1+ or 2+ cation or combination thereof;N is any 3+ or 4+ cation or combination thereof;K is the sum of the individual mole fractions of the 1+ cations;m is the sum of the individual mole fractions of the 2+ cations;n is the sum of the individual mole fractions of the 3+ cations;p is the sum of the individual mole fractions of the 4+ cations where either but not both of k and m or n and p can be zero and k+m+n+p=1.such compositons can be effective in removing unwanted colorants from detergent wash liquors thereby reducing colorant transfer in the wash.